caffeine has been researched along with Cancer of Prostate in 22 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Acetaldehyde formation was determined by GC-FID analysis in the head space of incubation mixtures." | 5.31 | Rat ventral prostate xanthine oxidase bioactivation of ethanol to acetaldehyde and 1-hydroxyethyl free radicals: analysis of its potential role in heavy alcohol drinking tumor-promoting effects. ( Castro, GD; Castro, JA; Costantini, MH; Delgado de Layño, AM, 2001) |
| "This study aimed to examine the acute effect of caffeine on exercise capacity, exercise-related fatigue, and functional performance in prostate cancer survivors." | 5.20 | Effect of caffeine on exercise capacity and function in prostate cancer survivors. ( Bolam, KA; Cornish, RS; Skinner, TL, 2015) |
| "We have examined the modulation of radiosensitivity by using caffeine in two human sarcoma cell lines both with a p53 mutation (US8-93 and LMS6-93)." | 3.71 | Loss of G2/M arrest correlates with radiosensitization in two human sarcoma cell lines with mutant p53. ( Bache, M; Bartel, F; Dunst, J; Meye, A; Pigorsch, S; Rath, FW; Schmidt, H; Taubert, H; Würl, P, 2001) |
| "Two human prostate cancer cell lines, PC-3 and DU145, were tested with increasing concentrations of caffeine, and their proliferative/metastatic features were evaluated." | 2.55 | Reduction by coffee consumption of prostate cancer risk: Evidence from the Moli-sani cohort and cellular models. ( Bonaccio, M; Cordella, M; Costanzo, S; D'Arcangelo, D; de Gaetano, G; Donati, MB; Facchiano, F; Filippo Di Castelnuovo, A; Iacoviello, L; Pounis, G; Rago, L; Tabolacci, C, 2017) |
| "In the treatment of prostate cancer, radiation therapy currently is being evaluated in combination with androgen deprivation (AD)." | 2.41 | Combined androgen deprivation with radiotherapy for prostate cancer: does it make sense? ( Garzotto, M, 2000) |
| "Coffee intake may lower prostate cancer risk and progression, but postdiagnosis outcomes by caffeine metabolism genotype are not well characterized." | 1.91 | Coffee Intake, Caffeine Metabolism Genotype, and Survival Among Men with Prostate Cancer. ( Berndt, SI; Brenner, H; Daniel, CR; Eeles, RA; Giles, GG; Gregg, JR; Hanash, S; Kim, J; Kogevinas, M; Logothetis, C; Manyam, G; Muir, K; Stanford, JL; Wei, P; Zhang, X, 2023) |
| "Prostate cancer was induced in rats with methylnitrosourea and testosterone and tumor incidence was determined." | 1.72 | Effects of green tea on prostate carcinogenesis in rat models and a human prostate cancer xenograft model. ( Bosland, MC; Condon, MS; Horton, L, 2022) |
| "Caffeine intake was not associated with cancer risk in a dose-response manner." | 1.42 | Coffee, tea, caffeine intake, and the risk of cancer in the PLCO cohort. ( Boffetta, P; Buys, SS; Galeone, C; Gren, L; Hashibe, M; La Vecchia, C; Zhang, ZF, 2015) |
| "Caffeine treatment increased the percentage of mitotic tumor cells undergoing apoptosis (lethal mitosis) whereas RW inhibited the increase in interleukin-6 that occurred during the progression of LNCaP tumors from androgen dependence to androgen independence." | 1.38 | Inhibition of progression of androgen-dependent prostate LNCaP tumors to androgen independence in SCID mice by oral caffeine and voluntary exercise. ( Conney, AH; Cui, XX; Huang, MT; Lee, MJ; Lin, Y; Liu, Y; Shih, WJ; Wagner, GC; Yang, CS; Zheng, X, 2012) |
| "From 1986 to 2006, 5035 patients with prostate cancer were identified, including 642 patients with lethal prostate cancers, defined as fatal or metastatic." | 1.37 | Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study. ( Giovannucci, E; Kasperzyk, JL; Kenfield, S; Mucci, LA; Rider, JR; Stampfer, MJ; van Dam, RM; Wilson, KM, 2011) |
| "We therefore used LNCaP human prostate cancer cells as a model to identify stimuli that lead to AIbZIP activation and define the transcriptional targets of AIbZIP." | 1.34 | Transcriptional profiling of genes that are regulated by the endoplasmic reticulum-bound transcription factor AIbZIP/CREB3L4 in prostate cells. ( Ben Aicha, S; Calvo, E; Fournier, A; Labrie, C; Lessard, J; Pelletier, M, 2007) |
| "Acetaldehyde formation was determined by GC-FID analysis in the head space of incubation mixtures." | 1.31 | Rat ventral prostate xanthine oxidase bioactivation of ethanol to acetaldehyde and 1-hydroxyethyl free radicals: analysis of its potential role in heavy alcohol drinking tumor-promoting effects. ( Castro, GD; Castro, JA; Costantini, MH; Delgado de Layño, AM, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.55) | 18.2507 |
| 2000's | 7 (31.82) | 29.6817 |
| 2010's | 10 (45.45) | 24.3611 |
| 2020's | 4 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Bosland, MC | 1 |
| Horton, L | 1 |
| Condon, MS | 1 |
| Gregg, JR | 2 |
| Kim, J | 2 |
| Logothetis, C | 1 |
| Hanash, S | 1 |
| Zhang, X | 1 |
| Manyam, G | 1 |
| Muir, K | 1 |
| Giles, GG | 1 |
| Stanford, JL | 2 |
| Berndt, SI | 1 |
| Kogevinas, M | 1 |
| Brenner, H | 1 |
| Eeles, RA | 1 |
| Wei, P | 1 |
| Daniel, CR | 2 |
| Steiner, B | 1 |
| Ferrucci, LM | 1 |
| Mirabello, L | 1 |
| Lan, Q | 1 |
| Hu, W | 1 |
| Liao, LM | 1 |
| Savage, SA | 1 |
| De Vivo, I | 1 |
| Hayes, RB | 1 |
| Rajaraman, P | 1 |
| Huang, WY | 1 |
| Freedman, ND | 1 |
| Loftfield, E | 1 |
| Pounis, G | 1 |
| Tabolacci, C | 1 |
| Costanzo, S | 1 |
| Cordella, M | 1 |
| Bonaccio, M | 1 |
| Rago, L | 1 |
| D'Arcangelo, D | 1 |
| Filippo Di Castelnuovo, A | 1 |
| de Gaetano, G | 1 |
| Donati, MB | 1 |
| Iacoviello, L | 1 |
| Facchiano, F | 1 |
| Wang, Z | 1 |
| Zhang, L | 1 |
| Wan, Z | 1 |
| He, Y | 1 |
| Huang, H | 1 |
| Xiang, H | 1 |
| Wu, X | 1 |
| Zhang, K | 1 |
| Liu, Y | 2 |
| Goodin, S | 1 |
| Du, Z | 1 |
| Zheng, X | 2 |
| Lopez, DS | 1 |
| Reichard, C | 1 |
| Zheng, J | 1 |
| Wu, W | 1 |
| Ye, Y | 1 |
| Chapin, B | 1 |
| Davis, J | 1 |
| Geybels, MS | 1 |
| Neuhouser, ML | 1 |
| Musialik, E | 1 |
| Ryszawy, D | 1 |
| Madeja, Z | 1 |
| Korohoda, W | 1 |
| Cornish, RS | 1 |
| Bolam, KA | 1 |
| Skinner, TL | 1 |
| Hodzic, J | 1 |
| Dingjan, I | 1 |
| Maas, MJ | 1 |
| van der Meulen-Muileman, IH | 1 |
| de Menezes, RX | 1 |
| Heukelom, S | 1 |
| Verheij, M | 1 |
| Gerritsen, WR | 1 |
| Geldof, AA | 1 |
| van Triest, B | 1 |
| van Beusechem, VW | 1 |
| Hashibe, M | 1 |
| Galeone, C | 1 |
| Buys, SS | 1 |
| Gren, L | 1 |
| Boffetta, P | 1 |
| Zhang, ZF | 1 |
| La Vecchia, C | 1 |
| McGreevy, KM | 1 |
| Lipsitz, SR | 1 |
| Linder, JA | 1 |
| Rimm, E | 1 |
| Hoel, DG | 1 |
| Wilson, KM | 1 |
| Kasperzyk, JL | 1 |
| Rider, JR | 1 |
| Kenfield, S | 1 |
| van Dam, RM | 1 |
| Stampfer, MJ | 1 |
| Giovannucci, E | 1 |
| Mucci, LA | 1 |
| Arab, L | 1 |
| Su, LJ | 1 |
| Steck, SE | 1 |
| Ang, A | 1 |
| Fontham, ET | 1 |
| Bensen, JT | 1 |
| Mohler, JL | 1 |
| Cui, XX | 1 |
| Huang, MT | 1 |
| Wagner, GC | 1 |
| Lin, Y | 1 |
| Shih, WJ | 1 |
| Lee, MJ | 1 |
| Yang, CS | 1 |
| Conney, AH | 1 |
| Ozono, S | 1 |
| Yamaguchi, A | 1 |
| Mochizuki, H | 1 |
| Kawakami, T | 1 |
| Fujimoto, K | 1 |
| Otani, T | 1 |
| Yoshida, K | 1 |
| Ichinei, M | 1 |
| Yamashita, T | 1 |
| Hirao, Y | 1 |
| Ben Aicha, S | 1 |
| Lessard, J | 1 |
| Pelletier, M | 1 |
| Fournier, A | 1 |
| Calvo, E | 1 |
| Labrie, C | 1 |
| Slattery, ML | 1 |
| West, DW | 1 |
| Mariot, P | 1 |
| Prevarskaya, N | 1 |
| Roudbaraki, MM | 1 |
| Le Bourhis, X | 1 |
| Van Coppenolle, F | 1 |
| Vanoverberghe, K | 1 |
| Skryma, R | 1 |
| Garzotto, M | 1 |
| Castro, GD | 1 |
| Delgado de Layño, AM | 1 |
| Costantini, MH | 1 |
| Castro, JA | 1 |
| Bache, M | 1 |
| Pigorsch, S | 1 |
| Dunst, J | 1 |
| Würl, P | 1 |
| Meye, A | 1 |
| Bartel, F | 1 |
| Schmidt, H | 1 |
| Rath, FW | 1 |
| Taubert, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Epidemiological Study of Risk Factors for Cardiovascular Disease and Tumors in an Adult Population of the Molise Region[NCT03242109] | 24,325 participants (Actual) | Observational | 2005-03-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for caffeine and Cancer of Prostate
| Article | Year |
|---|---|
Reduction by coffee consumption of prostate cancer risk: Evidence from the Moli-sani cohort and cellular models.
Topics: Aged; Caffeine; Cell Line, Tumor; Cell Proliferation; Coffee; Humans; Italy; Male; Middle Aged; Pros | 2017 |
Combined androgen deprivation with radiotherapy for prostate cancer: does it make sense?
Topics: Androgens; Apoptosis; Caffeine; Cell Cycle; Combined Modality Therapy; Humans; Male; Prostatic Neopl | 2000 |
2 trials available for caffeine and Cancer of Prostate
| Article | Year |
|---|---|
Effect of caffeine on exercise capacity and function in prostate cancer survivors.
Topics: Aged; Blood Pressure; Caffeine; Central Nervous System Stimulants; Cross-Over Studies; Double-Blind | 2015 |
Caffeine test in predicting flutamide-induced hepatic injury in patients with prostate cancer.
Topics: Aged; Androgen Antagonists; Caffeine; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP1A | 2002 |
18 other studies available for caffeine and Cancer of Prostate
| Article | Year |
|---|---|
Effects of green tea on prostate carcinogenesis in rat models and a human prostate cancer xenograft model.
Topics: Animals; Caffeine; Carcinogenesis; Disease Models, Animal; Drinking Water; Heterografts; Humans; Mal | 2022 |
Coffee Intake, Caffeine Metabolism Genotype, and Survival Among Men with Prostate Cancer.
Topics: Australia; Caffeine; Coffee; Cytochrome P-450 CYP1A2; Genotype; Humans; Male; Prostatic Neoplasms; R | 2023 |
Association between coffee drinking and telomere length in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Topics: Aged; Caffeine; Coffee; Colorectal Neoplasms; Cross-Sectional Studies; Female; Humans; Lung Neoplasm | 2020 |
Atorvastatin and Caffeine in Combination Regulates Apoptosis, Migration, Invasion and Tumorspheres of Prostate Cancer Cells.
Topics: Apoptosis; Atorvastatin; Caffeine; Cell Movement; Cell Proliferation; Humans; Hydroxymethylglutaryl- | 2020 |
Coffee, Caffeine Metabolism Genotype and Disease Progression in Patients with Localized Prostate Cancer Managed with Active Surveillance.
Topics: Aged; Caffeine; Coffee; Cytochrome P-450 CYP1A2; Disease Progression; Follow-Up Studies; Humans; Mal | 2019 |
Associations of tea and coffee consumption with prostate cancer risk.
Topics: Adult; Aged; Caffeine; Case-Control Studies; Coffee; Humans; Logistic Models; Male; Middle Aged; Odd | 2013 |
Morpho-physiological heterogeneity of cells within two rat prostate carcinoma cell lines AT-2 and MAT-LyLu differing in the degree of malignancy observed by cell cloning and the effects of caffeine, theophylline and papaverine upon a proportion of the clo
Topics: Animals; Caffeine; Cell Line, Tumor; Cell Movement; Clone Cells; Connexin 43; Male; Neoplasm Invasiv | 2013 |
A cell-based high-throughput screening assay for radiation susceptibility using automated cell counting.
Topics: Automation; Caffeine; Cell Survival; Central Nervous System Stimulants; Colony-Forming Units Assay; | 2015 |
Coffee, tea, caffeine intake, and the risk of cancer in the PLCO cohort.
Topics: Aged; Caffeine; Coffee; Colorectal Neoplasms; Female; Humans; Lung Neoplasms; Male; Middle Aged; Ova | 2015 |
Using median regression to obtain adjusted estimates of central tendency for skewed laboratory and epidemiologic data.
Topics: Bias; Caffeine; Clinical Laboratory Techniques; Fatty Acids; Humans; Male; Mass Screening; Prostatic | 2009 |
Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study.
Topics: Adult; Aged; Caffeine; Central Nervous System Stimulants; Coffee; Confounding Factors, Epidemiologic | 2011 |
Coffee consumption and prostate cancer aggressiveness among African and Caucasian Americans in a population-based study.
Topics: Adenocarcinoma; Adult; Aged; Black or African American; Caffeine; Coffee; Diet; Humans; Louisiana; M | 2012 |
Inhibition of progression of androgen-dependent prostate LNCaP tumors to androgen independence in SCID mice by oral caffeine and voluntary exercise.
Topics: Administration, Oral; Androgens; Animals; Apoptosis; Caffeine; Caspase 3; Cell Line, Tumor; Disease | 2012 |
Transcriptional profiling of genes that are regulated by the endoplasmic reticulum-bound transcription factor AIbZIP/CREB3L4 in prostate cells.
Topics: Adenocarcinoma; Amino Acid Sequence; Basic-Leucine Zipper Transcription Factors; Brefeldin A; Caffei | 2007 |
Smoking, alcohol, coffee, tea, caffeine, and theobromine: risk of prostate cancer in Utah (United States).
Topics: Aged; Alcohol Drinking; Caffeine; Case-Control Studies; Christianity; Coffee; Humans; Male; Matched- | 1993 |
Evidence of functional ryanodine receptor involved in apoptosis of prostate cancer (LNCaP) cells.
Topics: Apoptosis; Caffeine; Calcium; Flow Cytometry; Humans; Male; Prostatic Neoplasms; Reverse Transcripta | 2000 |
Rat ventral prostate xanthine oxidase bioactivation of ethanol to acetaldehyde and 1-hydroxyethyl free radicals: analysis of its potential role in heavy alcohol drinking tumor-promoting effects.
Topics: Acetaldehyde; Alcohol Drinking; Allopurinol; Animals; Antimetabolites; Caffeine; Carcinogens; Chroma | 2001 |
Loss of G2/M arrest correlates with radiosensitization in two human sarcoma cell lines with mutant p53.
Topics: Adenocarcinoma; Alleles; Apoptosis; Blotting, Western; Caffeine; Cell Survival; Combined Modality Th | 2001 |